Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain: Reply

Publikation: Bidrag til tidsskriftKommentar/debatForskning

Standard

Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain : Reply. / Fink-Jensen, Anders; Correll, Christoph U; Vilsbøll, Tina.

I: J A M A Psychiatry, Bind 74, Nr. 11, 11.2017, s. 1173-1174.

Publikation: Bidrag til tidsskriftKommentar/debatForskning

Harvard

Fink-Jensen, A, Correll, CU & Vilsbøll, T 2017, 'Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain: Reply', J A M A Psychiatry, bind 74, nr. 11, s. 1173-1174. https://doi.org/10.1001/jamapsychiatry.2017.2702

APA

Fink-Jensen, A., Correll, C. U., & Vilsbøll, T. (2017). Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain: Reply. J A M A Psychiatry, 74(11), 1173-1174. https://doi.org/10.1001/jamapsychiatry.2017.2702

Vancouver

Fink-Jensen A, Correll CU, Vilsbøll T. Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain: Reply. J A M A Psychiatry. 2017 nov.;74(11):1173-1174. https://doi.org/10.1001/jamapsychiatry.2017.2702

Author

Fink-Jensen, Anders ; Correll, Christoph U ; Vilsbøll, Tina. / Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain : Reply. I: J A M A Psychiatry. 2017 ; Bind 74, Nr. 11. s. 1173-1174.

Bibtex

@article{c369c1eee76b44cea6a47588bf06c370,
title = "Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain: Reply",
keywords = "Journal Article",
author = "Anders Fink-Jensen and Correll, {Christoph U} and Tina Vilsb{\o}ll",
year = "2017",
month = nov,
doi = "10.1001/jamapsychiatry.2017.2702",
language = "English",
volume = "74",
pages = "1173--1174",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "The JAMA Network",
number = "11",

}

RIS

TY - JOUR

T1 - Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain

T2 - Reply

AU - Fink-Jensen, Anders

AU - Correll, Christoph U

AU - Vilsbøll, Tina

PY - 2017/11

Y1 - 2017/11

KW - Journal Article

U2 - 10.1001/jamapsychiatry.2017.2702

DO - 10.1001/jamapsychiatry.2017.2702

M3 - Comment/debate

C2 - 28973062

VL - 74

SP - 1173

EP - 1174

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 11

ER -

ID: 185989416